Annual Total Assets
$608.48 M
+$266.63 M+77.99%
December 31, 2024
Summary
- As of March 14, 2025, SYRE annual total assets is $608.48 million, with the most recent change of +$266.63 million (+77.99%) on December 31, 2024.
- During the last 3 years, SYRE annual total assets has risen by +$498.56 million (+453.54%).
- SYRE annual total assets is now at all-time high.
Performance
SYRE Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$608.48 M
+$187.40 M+44.50%
December 31, 2024
Summary
- As of March 14, 2025, SYRE quarterly total assets is $608.48 million, with the most recent change of +$187.40 million (+44.50%) on December 31, 2024.
- Over the past year, SYRE quarterly total assets has increased by +$266.63 million (+77.99%).
- SYRE quarterly total assets is now at all-time high.
Performance
SYRE Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
SYRE Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +78.0% | +78.0% |
| 3 y3 years | +453.5% | +564.5% |
| 5 y5 years | +631.5% | +564.5% |
SYRE Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +755.3% | at high | +1060.1% |
| 5 y | 5-year | at high | +755.3% | at high | +1060.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Spyre Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $608.48 M(+78.0%) | $608.48 M(+44.5%) |
| Sep 2024 | - | $421.09 M(-3.4%) |
| Jun 2024 | - | $436.07 M(-10.6%) |
| Mar 2024 | - | $487.60 M(+42.6%) |
| Dec 2023 | $341.86 M(+380.5%) | $341.86 M(+64.9%) |
| Sep 2023 | - | $207.26 M(-14.9%) |
| Jun 2023 | - | $243.53 M(+364.3%) |
| Mar 2023 | - | $52.45 M(-26.3%) |
| Dec 2022 | $71.14 M(-35.3%) | - |
| Dec 2022 | - | $71.14 M(-22.3%) |
| Sep 2022 | - | $91.57 M(-14.2%) |
| Jun 2022 | - | $106.71 M(+28.3%) |
| Mar 2022 | - | $83.17 M(-24.3%) |
| Dec 2021 | $109.93 M(-32.0%) | $109.93 M(-14.8%) |
| Sep 2021 | - | $129.06 M(-12.2%) |
| Jun 2021 | - | $146.98 M(-10.2%) |
| Mar 2021 | - | $163.61 M(+1.2%) |
| Dec 2020 | $161.62 M(+94.3%) | $161.62 M(+3.8%) |
| Sep 2020 | - | $155.63 M(-10.0%) |
| Jun 2020 | - | $172.91 M(+166.9%) |
| Mar 2020 | - | $64.78 M(-22.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $83.18 M(+7.0%) | $83.18 M(-16.9%) |
| Sep 2019 | - | $100.10 M(-14.8%) |
| Jun 2019 | - | $117.49 M(-8.6%) |
| Mar 2019 | - | $128.52 M(+65.3%) |
| Dec 2018 | $77.74 M(+38.6%) | $77.74 M(+9.1%) |
| Sep 2018 | - | $71.28 M(-10.6%) |
| Jun 2018 | - | $79.71 M(+60.1%) |
| Mar 2018 | - | $49.79 M(-11.2%) |
| Dec 2017 | $56.08 M(-16.4%) | $56.08 M(-7.3%) |
| Sep 2017 | - | $60.50 M(-9.9%) |
| Jun 2017 | - | $67.14 M(+9.6%) |
| Mar 2017 | - | $61.27 M(-8.6%) |
| Dec 2016 | $67.06 M(+73.5%) | $67.06 M(-6.9%) |
| Sep 2016 | - | $72.06 M(-6.8%) |
| Jun 2016 | - | $77.30 M(+117.5%) |
| Mar 2016 | - | $35.54 M(-8.0%) |
| Dec 2015 | $38.65 M(+1219.2%) | $38.65 M(-8.2%) |
| Sep 2015 | - | $42.10 M(-7.8%) |
| Jun 2015 | - | $45.64 M(+2.9%) |
| Mar 2015 | - | $44.35 M(+1413.7%) |
| Dec 2014 | $2.93 M(-36.3%) | $2.93 M |
| Dec 2013 | $4.60 M | - |
FAQ
- What is Spyre Therapeutics annual total assets?
- What is the all time high annual total assets for Spyre Therapeutics?
- What is Spyre Therapeutics annual total assets year-on-year change?
- What is Spyre Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly total assets year-on-year change?
What is Spyre Therapeutics annual total assets?
The current annual total assets of SYRE is $608.48 M
What is the all time high annual total assets for Spyre Therapeutics?
Spyre Therapeutics all-time high annual total assets is $608.48 M
What is Spyre Therapeutics annual total assets year-on-year change?
Over the past year, SYRE annual total assets has changed by +$266.63 M (+77.99%)
What is Spyre Therapeutics quarterly total assets?
The current quarterly total assets of SYRE is $608.48 M
What is the all time high quarterly total assets for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly total assets is $608.48 M
What is Spyre Therapeutics quarterly total assets year-on-year change?
Over the past year, SYRE quarterly total assets has changed by +$266.63 M (+77.99%)